Migraine in the Emergency Department: A Prospective Multinational Study of Patient Characteristics, Management, and Outcomes

No Thumbnail Available
File version
Author(s)
Wijeratne, Tissa
Kuan, Win Sen
Kelly, Anne Maree
Chu, Kevin H
Kinnear, Frances B
Keijzers, Gerben
Body, Richard
Karamercan, Mehmet A
Klim, Sharon
Kamona, Sinan
Graham, Colin A
Roberts, Tom
Horner, Daniel
Laribi, Said
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2022
Size
File type(s)
Location
License
Abstract

Background and Aim: Migraine headache is commonly diagnosed in emergency departments (ED). There is relatively little real-world information about the epidemiology, investigation, management, adherence to therapeutic guidelines and disposition of patients treated in ED with a final diagnosis of migraine. The primary aim of the current study is to get a snapshot of assessment and management patterns of acute migraine presentations to the different settings of EDs with a view to raise awareness. Methods: This is a planned sub-study of a prospective study conducted in 67 health services in 10 countries including Australia, New Zealand, Southeast Asia, Europe, and the UK investigating the epidemiology and outcome of adult patients presenting to ED with nontraumatic headache. Outcomes of interest for this study are demographics, clinical features (including severity), patterns of investigation, treatment, disposition, and outcome of patients diagnosed as having migraine as their final ED diagnosis. Results: The cohort comprises 1,101 patients with a mean age of 39 years (SD ± 13.5; 73.7% [811]) were female. Most patients had had migraine diagnosed previously (77.7%). Neuroimaging was performed in 25.9% with a very low diagnostic yield or significant findings (0.07%). Treatment of mild migraine was in accordance with current guidelines, but few patients with moderate or severe symptoms received recommended treatment. Paracetamol (46.3%) and nonsteroidal anti-inflammatory drugs (42.7%) were the most commonly prescribed agents. Metoclopramide (22.8%), ondansetron (19.2%), chlorpromazine (12.8%), and prochlorperazine (12.8%) were also used. Conclusions: This study suggests that therapeutic practices are not congruent with current guidelines, especially for patients with severe symptoms. Efforts to improve and sustain compliance with existing management best practices are required.

Journal Title

Neuroepidemiology

Conference Title
Book Title
Edition
Volume

56

Issue

1

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Neurosciences

Science & Technology

Life Sciences & Biomedicine

Public, Environmental & Occupational Health

Clinical Neurology

Neurosciences & Neurology

Persistent link to this record
Citation

Wijeratne, T; Kuan, WS; Kelly, AM; Chu, KH; Kinnear, FB; Keijzers, G; Body, R; Karamercan, MA; Klim, S; Kamona, S; Graham, CA; Roberts, T; Horner, D; Laribi, S, Migraine in the Emergency Department: A Prospective Multinational Study of Patient Characteristics, Management, and Outcomes, Neuroepidemiology, 2022, 56 (1), pp. 32-40

Collections